Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.50
Delayed Data
As of Feb 27
 +0.41 / +37.61%
Today’s Change
0.51
Today|||52-Week Range
4.14
+114.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues686.0K699.0K69.0K1.1M
 
 
 
 
 
Cost of Goods Sold418.0K119.0K----
 
 
 
Depreciation And Amortization457.0K241.0K60.0K70.0K
 
 
 
 
 
 
Operating ExpensesGross Income-189.0K339.0K----
 
 
 
General Expenses--16.7M15.1M19.0M
 
 
 
 
Research And Development--9.2M6.6M11.3M
 
 
 
 
Total Operating Expenses--17.1M15.2M19.1M
 
 
 
 
 
Non-Operating ExpensesOperating Income---16.4M-15.1M-18.0M
 
 
 
 
Extraordinary Credit--629.0K28.0K570.0K
 
 
 
 
Extraordinary Charge---20.0K0.000.00
 
 
Interest Expense On Debt43.0K0.000.00--
 
 
Other Expenses---74.0K-54.0K5.5M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.7M-15.8M-15.1M-11.9M
 
 
 
 
 
Income Taxes---565.0K-1.4M-1.7M
 
 
 
 
Preferred Dividend-3.7M-728.0K-728.0K-9.3M
 
 
 
 
 
Discontinued Operations--0.00570.0K57.0K
 
 
 
Net Income-16.0M-15.2M-13.2M-10.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.4M7.2M8.3M15.2M
 
 
 
 
 
Shares To Calculate EPS Diluted5.4M7.2M8.3M15.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.64-$2.24-$1.68-$1.28
 
 
 
 
 
EPS Diluted-$3.64-$2.24-$1.68-$1.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account